The Founder Journey in Biotech

The Story

Great science is only the beginning. Building a successful biotech company requires disciplined execution, strategic judgment, and exceptional people. Those realities were front and center during The Founder Journey in Biotech, an evening event held at UC Berkeley on November 10, 2026, that brought together experienced biotech founders—several of whom are repeat entrepreneurs—for a candid conversation about building and scaling startups.

Four leaders anchored the discussion: Dr. Nicholas Hertz (CEO, Montara Therapeutics), Dr. Armon Sharei (Founder & CEO, Portal Biotechnologies), Dr. Ashley Zehnder (Co-founder, Fauna Bio), and Dr. Adam Schieferecke (Co-founder, Vivere). Rather than sticking to surface-level success stories, the panelists shared hard-earned lessons and honest perspectives on what it actually takes to navigate the early stages of a life sciences company.

The energy in the room was driven by an engaged audience of UC Berkeley graduate students. Their thoughtful questions sparked such a lively dialogue that the conversation easily could have continued for another hour, highlighting the value of connecting seasoned founders directly with the next generation of biotech entrepreneurs.

Key Takeaways

1. Be radically capital-efficient and ask the hard questions early.

Dr. Hertz emphasized the importance of running "Type 1 experiments"—experiments designed to generate actionable insights regardless of the outcome. Getting bad news early is far better than getting bad news late. Staying lean preserves runway, strengthens negotiating leverage, and protects the freedom to make strategic decisions.
2. Maintain strategic optionality.

Dr. Sharei and Dr. Zehnder shared valuable lessons on partnering with big pharma. While corporate partnerships can be transformative, relying entirely on a single partner leaves a startup vulnerable to shifting external priorities and lengthy decision-making timelines. Maintaining independent internal programs and creating competitive urgency can make all the difference.

3. Learn to delegate and bet on people, not just credentials.

Dr. Schieferecke reminded the room that while scientists are trained to do everything themselves at the bench, successful founders must eventually learn to delegate. Dr. Sharei and Dr. Zehnder also stressed the value of identifying ambitious, high-potential talent within the organization rather than relying solely on experienced external hires.

Meet the Voices & Collaborators

Our Panelists:

  • Nicholas Hertz, PhD — CEO, Montara Therapeutics

  • Armon Sharei, PhD — Founder & CEO, Portal Biotechnologies

  • Ashley Zehnder, DVM, PhD — Co-founder, Fauna Bio

  • Adam Schieferecke, PhD — Co-founder, Vivere

Our Co-Hosting Collaborators & Organizers:

  • Biotech @Berkeley (B²)

  • Bakar Bio Labs

  • Berkeley Pharma Tech Foundation

  • Julia Jamieson

  • Himani Gupta, MBBS MD

Next
Next

Future of Healthtech × AI: One Way Pitch Competition